Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Indiana for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Indiana only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Indiana (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Mary Ann Domingo (NPI 1053396127)

Field	Value
Entity Type	Individual
Organization	Mary Ann Domingo
Address	6901 N Main St Ste 102
City	Granger
State	IN
ZIP	46530
Taxonomy	Rheumatology Physician
NPI Enumerated	December 13, 2005

Payer Source	Total Paid
Medicare	$1.4M
Medicaid	$0

Key Findings

MARY ANN DOMINGO is a Rheumatology Physician in GRANGER, IN with an NPI enumerated on 2005-12-13 (~21 years ago). Lifetime Medicare revenue on file is $1.4M and there is no Medicaid billing on file, indicating the provider’s public-payer footprint is effectively single-payer Medicare rather than a dual Medicare/Medicaid mix.

Revenue for this provider is heavily concentrated in a small set of biologic drug administration codes: the top 3 Medicare codes (J0129, J3262, J0717) account for 67.2% of total Medicare revenue. Individually, J0129 represents 32.4% of Medicare revenue, J3262 represents 24.2%, and J0717 represents 10.6%, showing a dominant reliance on a few high-cost injectable therapies.

The CPT/HCPCS mix and service codes point to an infusion- and injection-focused rheumatology practice rather than a pure office-visits model. High-revenue biologics such as J0129 (abatacept), J3262 (tocilizumab), J0717 (certolizumab), and the presence of infusion administration codes like 96365 (391 claims, $45 avg paid/claim, $17.6K revenue) and chemotherapy/infusion add-on codes such as 96413 (128 claims, $94 avg paid/claim, $12K revenue) indicate in-office parenteral therapy and supervised infusion services are a central part of operations.

Competitive standing on the top biologics is generally middle-of-market rather than dominant: J0129 ranks #287 of 1221 providers nationally (77th percentile; typical, unremarkable volume), J3262 ranks #139 of 618 providers nationally (78th percentile; typical, unremarkable volume), while J0717 ranks #551 of 848 providers nationally (35th percentile; typical, unremarkable volume). These ranks suggest the provider is a meaningful but not market-leading participant in national biologic administration for those agents.

Office visit and infusion procedure volume places the provider above many peers for outpatient management and administered therapies. The E/M code 99214 appears at notably high relative volume (709 claims, $79 avg paid/claim, $56K revenue; ranks #25524 of 479517 providers nationally, 95th percentile; notably above typical national volume) and the initial IV infusion code 96365 is also high (93th percentile), indicating sustained patient-management throughput and frequent supervised drug administration.

The provider’s revenue mix includes additional biologics and related therapies beyond the top three, providing some diversification within the drug-administration service line. Examples include J1745 (infliximab, $131.6K revenue, 9.4% of Medicare revenue; rank #370 of 1352, 73th percentile), J0897 (denosumab, $119.9K revenue, 8.5% of Medicare revenue; rank #2007 of 10057, 80th percentile), and J1602 (golimumab, $91.8K revenue, 6.5% of Medicare revenue; rank #763 of 1041, 27th percentile), which together indicate a portfolio of infusion/injection therapies with mixed national standing.

The absence of any Medicaid billing on file (listed as "none below") means there is no in-state Medicaid performance data to assess competitive positioning within Indiana Medicaid networks. For payer strategy and network negotiations this profile should be treated as Medicare-dominant; any assessment of Medicaid participation or state-level access must rely on other sources or direct inquiry.

Taken together, long tenure (NPI since 2005-12-13, ~21 years), a $1.4M Medicare revenue base, and a code mix dominated by high-revenue biologic injections imply an established rheumatology practice with integrated infusion services that depends disproportionately on a few high-value drug administration codes for the majority of its Medicare income. This concentration creates exposure to shifts in biologic utilization, reimbursement, or site-of-care policies affecting infused or physician-administered medications.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

21 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	13,780	$30	$454.6K
J3262	Injection, tocilizumab, 1 mg	67,900	$10	$339.5K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	37,000	$1	$148K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	5,060	$30	$131.6K
J0897	Injection, denosumab, 1 mg	6,660	$20	$119.9K
J1602	Injection, golimumab, 1 mg, for intravenous use	8,340	$10	$91.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	710	$80	$56K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	390	$50	$17.6K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	270	$60	$15.4K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	130	$90	$12K

Showing 1–10 of 21

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Indiana Distribution

Mary Ann Domingo — 2 of 21 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Indiana

Full comparison — all codes billed, vs. state median

21 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	10	30	10,630	$30	$391.1K
J3262	4	10	46,210	$1	$263.4K
J0717	12	20	42,400	$1	$198.8K
J1602	11	20	9,500	$10	$167.1K
J1745	6	20	3,990	$30	$119.4K
J0897	38	220	2,730	$20	$74.9K
96413	62	120	140	$90	$19.1K
99214	452	10,540	110	$80	$15.5K
99213	1,479	10,820	80	$50	$7.6K
96365	7	140	80	$40	$5.2K

Showing 1–10 of 21

Related Providers

Other providers that share a Tax Identification Number (TIN) with Mary Ann Domingo, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Memorial Hospital Of South Bend	IN	General Acute Care Hospital	$0	$33.3M
La Porte Clinic Company LLC	IN	Internal Medicine Physician	$0	$18.8M
Beacon Medical Group, Inc.	IN	Urgent Care Clinic/Center	$0	$7.2M
William Paul	IN	Oral and Maxillofacial Surgery (Dentist)	$0	$5.4M
Beacon Medical Group, Inc.	IN	Pediatrics Physician	$0	$4.7M
Beacon Medical Group, Inc.	IN	Family Medicine Physician	$0	$4.7M
Beacon Medical Group, Inc.	IN	Critical Care Medicine (Internal Medicine) Physician	$0	$4.6M
Beacon Medical Group, Inc.	IN	Psychiatry Physician	$0	$4.4M
Beacon Medical Group, Inc.	IN	Family Medicine Physician	$0	$3.4M
Natali Balog	IN	Rheumatology Physician	$2.4M	$0

Nearby Providers

Other providers in the same ZIP code as Mary Ann Domingo, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Kevin Kristl	IN	Neurology Physician	$110.8K	$548.8K
South Bend Specialty Surgery Center, LLC	IN	Ambulatory Surgical Clinic/Center	$540.5K	$16.8K
Asc Surgical Ventures, LLC	IN	Ambulatory Surgical Clinic/Center	$276.8K	$0
Sara Golden	IN	Family Nurse Practitioner	$222.9K	$0
Brad Sandler	IN	Neuromusculoskeletal Medicine & OMM Physician	$176.3K	$0
Paul Smucker	IN	Physical Medicine & Rehabilitation Physician	$168.9K	$0
Christopher Quinn	IN	Family Medicine Physician	$153.1K	$0
Walter Kolmodin	IN	Podiatrist	$118.4K	$0
Bradley Scott	IN	Family Medicine Physician	$117.2K	$0
Randolph Ferlic	IN	Orthopaedic Hand Surgery Physician	$114K	$0

Mary Ann Domingo — Billing Profile & Reimbursement Data

Sign up for Mary Ann Domingo — Billing Profile & Reimbursement Data policy alerts

Mary Ann Domingo — Billing Profile & Reimbursement Data

Sign up for Mary Ann Domingo — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References